WebFeb 4, 2024 · Proviral-integration site for Moloney-murine leukemia virus (PIM) proteins i.e., PIM1, PIM2 and PIM3 belong to a family of serine/threonine protein kinases and depend on Ca 2+ /calmodulin protein kinase group. These kinases are short lived and active with highly overlapping functions, reviewed in [ 7 ].
Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC - PMC
WebApr 1, 2024 · Overall, we have identified PIM1 as a metabolic modulator in MDSCs that is associated with ICB resistance and can be therapeutically targeted to overcome ICB resistance. Introduction Immune checkpoint blockade (ICB) has generated remarkable responses in treating cancer ( 1, 2 ). WebMay 19, 2016 · Luciferase assays with the Pim1 3′-UTR found no decrease by miR-124a . microRNAs miR-33a (a known Pim1 target) 21 and miR-214 (a putative high-seed match to the Pim1 3′UTR), both targeted Pim1 . Although the effects of miR-33a were previously reported, this is the first report demonstrating that miR-214 can directly target the Pim1 … 60毒王加点
PIM serine/threonine kinases in the pathogenesis and …
WebFeb 9, 2010 · Interestingly, the half-life of PIM1 (< 5 min) observed in normal peripheral leukocytes was significantly increased in K562, a Philadelphia chromosome-positive … WebMay 7, 2024 · Proviral integration site for Moloney-murine leukemia 1 (PIM1) is a known JAK-STAT target gene that recently emerged as a therapeutic target for the treatment of T-ALL and T-LBL. 2-7 PIM1 activation in primary T-ALL/T-LBLs can occur through T-cell receptor–driven translocations 5,6 or activating mutations targeting IL7RA, JAK1, JAK3, … WebDec 7, 2024 · Here, we used Targeted Locus Amplification (TLA, de Vree et al., Nat Biotechnol., 2014) to identify a novel TCRβ driven t(6;7)(p21;q34) translocation in a human T-LBL patient resulting in aberrant activation of the PIM1 proto-oncogene. PIM1 is a constitutively active serine/threonine kinase involved in cell cycle progression, apoptosis ... 60毛等于多少元